HeLa In Vitro Anti-Tumor Efficacy Assay

This assay is to provide HeLa-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

HeLa

Human

In 1952, HeLa cells became the first human cell line that could grow and divide endlessly in a laboratory, leading scientists to label these cells "immortal". The immortality of HeLa cells contributed to their adoption across the world as the human cell line of choice for biomedical research.

Cervical Cancer

Oncology

In Vitro Anti-Tumor Efficacy Assay

HeLa-cell based In Vitro Anti-Tumor Efficacy Assay

Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.

Oncology Efficacy Assays